CHORUS AVIATION INC (CHR.CA) Fundamental Analysis & Valuation

TSX:CHRCA17040T8885

Current stock price

22.62 CAD
-0.05 (-0.22%)
Last:

This CHR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CHR was profitable.
  • CHR had a positive operating cash flow in the past year.
  • In multiple years CHR reported negative net income over the last 5 years.
  • CHR had a positive operating cash flow in each of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.01%, CHR belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • With an excellent Return On Equity value of 15.50%, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CHR has a better Return On Invested Capital (7.56%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 5.94%.
  • The last Return On Invested Capital (7.56%) for CHR is above the 3 year average (6.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.01%
ROE 15.5%
ROIC 7.56%
ROA(3y)-2.94%
ROA(5y)-1.76%
ROE(3y)-10.29%
ROE(5y)-6.33%
ROIC(3y)6.55%
ROIC(5y)5.67%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

1.3 Margins

  • The Profit Margin of CHR (5.98%) is better than 83.33% of its industry peers.
  • CHR's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 7.57%, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CHR has declined.
  • CHR has a Gross Margin of 67.08%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
  • CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.57%
PM (TTM) 5.98%
GM 67.08%
OM growth 3Y-16.68%
OM growth 5Y-17.04%
PM growth 3Y54.29%
PM growth 5Y6.46%
GM growth 3Y-2.08%
GM growth 5Y-3.91%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. CHR.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
  • Compared to 1 year ago, CHR has less shares outstanding
  • Compared to 5 years ago, CHR has more shares outstanding
  • The debt/assets ratio for CHR has been reduced compared to a year ago.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.94, we must say that CHR is in the distress zone and has some risk of bankruptcy.
  • CHR has a Altman-Z score (0.94) which is in line with its industry peers.
  • CHR has a debt to FCF ratio of 13.43. This is a negative value and a sign of low solvency as CHR would need 13.43 years to pay back of all of its debts.
  • The Debt to FCF ratio of CHR (13.43) is better than 83.33% of its industry peers.
  • A Debt/Equity ratio of 0.61 indicates that CHR is somewhat dependend on debt financing.
  • CHR's Debt to Equity ratio of 0.61 is amongst the best of the industry. CHR outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 13.43
Altman-Z 0.94
ROIC/WACC0.89
WACC8.48%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that CHR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.30, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Quick Ratio of 0.69 indicates that CHR may have some problems paying its short term obligations.
  • CHR has a Quick ratio (0.69) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.69
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2

3. CHR.CA Growth Analysis

3.1 Past

  • CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.94%, which is quite impressive.
  • Measured over the past years, CHR shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.51% on average per year.
  • Looking at the last year, CHR shows a decrease in Revenue. The Revenue has decreased by -6.30% in the last year.
  • The Revenue has been growing slightly by 6.77% on average over the past years.
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-6.21%
Revenue growth 5Y6.77%
Sales Q2Q%-9.33%

3.2 Future

  • Based on estimates for the next years, CHR will show a decrease in Earnings Per Share. The EPS will decrease by -8.54% on average per year.
  • Based on estimates for the next years, CHR will show a decrease in Revenue. The Revenue will decrease by -0.24% on average per year.
EPS Next Y-18.54%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
EPS Next 5Y-8.54%
Revenue Next Year-4.3%
Revenue Next 2Y-1.72%
Revenue Next 3Y-0.35%
Revenue Next 5Y-0.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. CHR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CHR is valuated reasonably with a Price/Earnings ratio of 9.43.
  • CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (25.23), we can say CHR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.57, the valuation of CHR can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CHR is valued a bit cheaper than 66.67% of the companies in the same industry.
  • CHR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.51.
Industry RankSector Rank
PE 9.43
Fwd PE 11.57
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CHR is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.99
EV/EBITDA 4.23
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The excellent profitability rating of CHR may justify a higher PE ratio.
  • A cheap valuation may be justified as CHR's earnings are expected to decrease with -7.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%

5

5. CHR.CA Dividend Analysis

5.1 Amount

  • CHR has a Yearly Dividend Yield of 1.62%. Purely for dividend investing, there may be better candidates out there.
  • CHR's Dividend Yield is a higher than the industry average which is at 1.00.
  • CHR's Dividend Yield is comparable with the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • The dividend of CHR is nicely growing with an annual growth rate of 6.02%!
  • CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.02%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 1 2 3

5.3 Sustainability

  • 4.99% of the earnings are spent on dividend by CHR. This is a low number and sustainable payout ratio.
DP4.99%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M
CHR.CA Dividend Payout.CHR.CA Dividend Payout, showing the Payout Ratio.CHR.CA Dividend Payout.PayoutRetained Earnings

CHR.CA Fundamentals: All Metrics, Ratios and Statistics

CHORUS AVIATION INC

TSX:CHR (3/26/2026, 7:00:00 PM)

22.62

-0.05 (-0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners4.93%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap529.08M
Revenue(TTM)1.32B
Net Income(TTM)78.74M
Analysts80
Price Target31.18 (37.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.16
Dividend Growth(5Y)6.02%
DP4.99%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.44%
Min EPS beat(2)-12.73%
Max EPS beat(2)3.86%
EPS beat(4)3
Avg EPS beat(4)1.51%
Min EPS beat(4)-12.73%
Max EPS beat(4)11.03%
EPS beat(8)6
Avg EPS beat(8)21.63%
EPS beat(12)6
Avg EPS beat(12)4.92%
EPS beat(16)7
Avg EPS beat(16)0.38%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.93%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.95%
Revenue beat(8)1
Avg Revenue beat(8)-4.99%
Revenue beat(12)4
Avg Revenue beat(12)-2.69%
Revenue beat(16)6
Avg Revenue beat(16)-1.25%
PT rev (1m)3.38%
PT rev (3m)3.05%
EPS NQ rev (1m)2.45%
EPS NQ rev (3m)2.45%
EPS NY rev (1m)-2.24%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)-3.8%
Revenue NQ rev (3m)-3.8%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 9.43
Fwd PE 11.57
P/S 0.4
P/FCF 18.99
P/OCF 8.43
P/B 1.04
P/tB 1.07
EV/EBITDA 4.23
EPS(TTM)2.4
EY10.61%
EPS(NY)1.96
Fwd EY8.64%
FCF(TTM)1.19
FCFY5.26%
OCF(TTM)2.68
OCFY11.86%
SpS56.28
BVpS21.71
TBVpS21.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number34.24
Profitability
Industry RankSector Rank
ROA 6.01%
ROE 15.5%
ROCE 9.47%
ROIC 7.56%
ROICexc 7.77%
ROICexgc 7.87%
OM 7.57%
PM (TTM) 5.98%
GM 67.08%
FCFM 2.12%
ROA(3y)-2.94%
ROA(5y)-1.76%
ROE(3y)-10.29%
ROE(5y)-6.33%
ROIC(3y)6.55%
ROIC(5y)5.67%
ROICexc(3y)7.32%
ROICexc(5y)6.2%
ROICexgc(3y)7.4%
ROICexgc(5y)6.25%
ROCE(3y)8.21%
ROCE(5y)7.1%
ROICexgc growth 3Y14.68%
ROICexgc growth 5Y8.46%
ROICexc growth 3Y14.56%
ROICexc growth 5Y8.27%
OM growth 3Y-16.68%
OM growth 5Y-17.04%
PM growth 3Y54.29%
PM growth 5Y6.46%
GM growth 3Y-2.08%
GM growth 5Y-3.91%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 13.43
Debt/EBITDA 1.49
Cap/Depr 32.52%
Cap/Sales 2.65%
Interest Coverage 5.51
Cash Conversion 30.33%
Profit Quality 35.38%
Current Ratio 1.3
Quick Ratio 0.69
Altman-Z 0.94
F-Score7
WACC8.48%
ROIC/WACC0.89
Cap/Depr(3y)32.03%
Cap/Depr(5y)32.8%
Cap/Sales(3y)3.17%
Cap/Sales(5y)4.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
EPS Next Y-18.54%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
EPS Next 5Y-8.54%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-6.21%
Revenue growth 5Y6.77%
Sales Q2Q%-9.33%
Revenue Next Year-4.3%
Revenue Next 2Y-1.72%
Revenue Next 3Y-0.35%
Revenue Next 5Y-0.24%
EBIT growth 1Y4.51%
EBIT growth 3Y-21.86%
EBIT growth 5Y-11.43%
EBIT Next Year72.5%
EBIT Next 3Y17.02%
EBIT Next 5Y10.81%
FCF growth 1Y-86.87%
FCF growth 3Y-49.57%
FCF growth 5YN/A
OCF growth 1Y-76.32%
OCF growth 3Y-39.22%
OCF growth 5Y-16.72%

CHORUS AVIATION INC / CHR.CA Fundamental Analysis FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 9.43 and the Price/Book (PB) ratio is 1.04.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 5 / 10.